A recent prospective randomized controlled study gave a single dose of FCM (800–1000 mg) in patients with functional iron deficiency anemia at POD1, and the mean Hb level demonstrated improvement at 4 weeks after the operation in the FCM group [23]. This evidence concerns the gene GSTM1 and Iron deficiency anemia.